EVALUATION OF COMPLIANCE WITH TUBERCULOSIS PATIENTS IN CONSUMING ANTI-TUBERCULOSIS MEDICINE (OAT) IN OUTPATIENT PATIENTS AT THE HEALTH CENTER WHEN

Tia Fitria Tamrin; Ahmad Husain  Palli; Atvinda Pirlya Afista

doi:10.47918/jhts.v4i4.436

Tia Fitria Tamrin Universitas Bina Mandiri
Ahmad Husain Palli Universitas Bina Mandiri Gorontalo
Atvinda Pirlya Afista Universitas Bina Mandiri Gorontalo

DOI: https://doi.org/10.47918/jhts.v4i4.436

Abstrak

Penelitian ini bertujuan untuk mengetahui tingkat kepatuhan pasien, karakteristik pasien TB paru dan untuk mengetahui faktor yang mempengaruhi kepatuhan pada pasien rawat jalan di Puskesmas Kabila. Penelitian dilakukan dengan menggunakan pendekatan kuantitatif, Populasi dalam penelitian ini adalah seluruh pasien tuberculosis rawat jalan di Puskesmas Kabila sejumlah 28 orang teknik pengambilan sampel yang digunakan dalam penelitian ini adalah total sampling. penelitianini merupakan penelitian deskriptif yang dilakukan secara observasional dengan menggunakan instrumen penelitian yaitu, Formulir Informed Consentdan Kuesioner MMAS-8. Analisis data yang dilakukan menggunakan analisis data deskriptif.

Hasil peneltian karakteristik pasien terdiri dari jenis kelamin, usia, pendidikan dan pekerjaan, pasien di puskesmas kabla memiliki tingkat kepatuhan yang tinggi dalam penggunaan obat untuk proses penyembuhan penyakit TB, hal tersebut dapat di lihat pada hasil penelitian di atas dimana tingkat kepatuhan pasien memperoleh kategori tinggi yaitu berjumlah 23 orang atau sebesar 82.14%% rendah 5 atau 17.85%.

Kata Kunci: Kepatuhan, Tuberculosis, Mengkonsumsi OAT.

Referensi

[1] Arditia, 2018. The Correlation of Characteristics, Knowledge, Attitudes and Actions of Pulmonary Tuberculosis Patients with Drug Compliance at Taah Kalikewall Health Center. [Thesis thesis]. Airlangga University.
[2] Ana, S. 2012. Evaluation of Drug Use Compliance in Outpatient Tuberculosis Patients at the Surakarta Community Pulmonary Health Center 2012. Thesis. Faculty of Pharmacy. Muhammadiyah Surakarta university.
[3] Armelia, 2011 Evaluation of Compliance with Medication for Patients with Pulmonary Tuberculosis in 2010-2011 at the Pancoran Mas District Health Center, Depok, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Indonesia.
[4] Arsin, A., & Azriful. 2004. Several Factors Related to the Incidence of Pulmonary Tuberculosis in the Working Area of Kassi Makassar Public Health Center. Journal of Medika Nusantara, 25 (3). Makassar. Pages: 39-40.
[5] Asrul et al, Evaluation of the Use of Antituberculosis Drugs (OAT) in Pulmonary Tuberculosis Patients at Jumpandang Baru Health Center Makassar, Department of Pharmacy FKIF Alauddin State Islamic University Makassar.
[6] Aditama, TY 2002. Tuberculosis Diagnosis, Treatment and Problems. 5th Edition. Indonesian Doctors Association Publishing Foundation, Jakarta.
[7] Centers for Disease Control and Prevention (CDC). 2013 Latent Tuberculosis Infection: A Guide for

Primary Health Care Providers. Available:
[8] Darmanto, D., 2014. Respirology. Issue 2.: EGC Medical Book Publisher. Jakarta
[9] Danusantoso, H., 2012. Pocket Book of Lung Disease. Jakarta: Hippocrates
[10] Indonesian Ministry of Health, 2018. Tuberculosis.: Data and Information Center of the Indonesian Ministry of Health. Jakarta.
[11] Ministry of Health of the Republic of Indonesia, 2014, National Guidelines for Tuberculosis Control, Edition 2, 30-31, MOH, 2014, Jakarta.
[12] South Sulawesi Provincial Health Office. 2014. Health Profile of South Sulawesi. Makassar Dipiro, JT, Wells, BG, Schwinghammer, TL,
[13] Ministry of Health of the Republic of Indonesia 2011. National Guidelines for the Prevention of Tuberculosis. Directorate General of Disease Control and Environmental Health. Jakarta.
[14] Ministry of Health of the Republic of Indonesia. 2009. Indonesian Health Profile. Indonesian Ministry of Health, Jakarta.
[15] Bantul District Health Department. 2016. Health ProfileBantul Regency, Yogyakarta Special Region.
[16] Indonesian Ministry of Health. 2008. National Guidelines for Tuberculosis Management, : Gedurnas TB. Issue 2 p. 4-6. Jakarta
[17] Indonesian Ministry of Health. 2007. Pharmaceutical Care for Tuberculosis.
Jakarta:
[18] Ministry of Health of the Republic of Indonesia. Pages: 6, 14-28,
30.
[19] Indonesian Ministry of Health. 2002, National Guidelines for Combating Tuberculosis, 8th Print. Jakarta.
[20] Bone Bolango Health Service 2020, TB Prevalence Data in Each District.
[21] Dipiro, CV Pharmacotherapy Handbook, Seventh Edition,.2009.532-533, McGraw-Hill Medical, New York.
[22] Hastono. SP. 2017, Health statistics. Jakarta: Rajawali Press.